Nisa Investment Advisors
BCAX

Nisa Investment Advisors’s Bicara Therapeutics BCAX Stock Holding History

Nisa Investment Advisors’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.2K Sell
161
-409
-72% -$7.04K ﹤0.01% 2540
2025
Q4 		$9.59K Buy
570
+409
+254% +$6.99K ﹤0.01% 2245
2025
Q3 		$2.54K Buy
+161
New +$1.8K ﹤0.01% 2573
2025
Q2 		– Sell
-163
Closed -$2.12K – 3108
2025
Q1 		$2.12K Buy
+163
New +$2.17K ﹤0.01% 2452

Other funds holding BCAX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RTM
Red Tree Management Redwood City, California $112M AUM 91.52% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Nisa Investment Advisors's BCAX Position: Q1 2026 in Review

Nisa Investment Advisors reduced its Bicara Therapeutics (BCAX) stake by 72% in Q1 2026, selling an estimated $7.04K and leaving 161 shares worth $3.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2540.

Nisa Investment Advisors first reported a position in BCAX in Q1 2025 and has held it in 4 quarters since. The position peaked at $9.59K in Q4 2025. 146 funds tracked by Wall St. Rank hold BCAX as of Q1 2026.

  • Nisa Investment Advisors held 161 shares of Bicara Therapeutics worth $3.2K as of Q1 2026.
  • Nisa Investment Advisors sold 409 Bicara Therapeutics shares in Q1 2026, an estimated $7.04K.
  • Bicara Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2540 holding.
  • Nisa Investment Advisors first reported a position in Bicara Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • Nisa Investment Advisors's Bicara Therapeutics position peaked at $9.59K in Q4 2025.
  • 146 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.